Owens & Minor ROE 2010-2025 | OMI

Current and historical return on equity (ROE) values for Owens & Minor (OMI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Owens & Minor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.37B $0.57B -50.60%
2024-12-31 $-0.36B $0.59B -45.14%
2024-09-30 $-0.05B $0.88B -5.51%
2024-06-30 $-0.04B $0.86B -4.71%
2024-03-31 $-0.04B $0.90B -4.22%
2023-12-31 $-0.04B $0.92B -4.41%
2023-09-30 $-0.12B $0.89B -12.70%
2023-06-30 $-0.10B $0.90B -10.50%
2023-03-31 $-0.04B $0.92B -4.32%
2022-12-31 $0.02B $0.95B 2.30%
2022-09-30 $0.12B $0.97B 12.80%
2022-06-30 $0.15B $0.96B 16.50%
2022-03-31 $0.19B $0.95B 21.09%
2021-12-31 $0.22B $0.94B 25.66%
2021-09-30 $0.23B $0.89B 28.58%
2021-06-30 $0.23B $0.85B 33.32%
2021-03-31 $0.11B $0.79B 18.94%
2020-12-31 $0.03B $0.71B 6.08%
2020-09-30 $-0.06B $0.45B -13.92%
2020-06-30 $-0.11B $0.40B -23.81%
2020-03-31 $-0.06B $0.42B -12.65%
2019-12-31 $-0.06B $0.46B -12.70%
2019-09-30 $-0.28B $0.49B -56.57%
2019-06-30 $-0.29B $0.50B -49.55%
2019-03-31 $-0.46B $0.50B -70.24%
2018-12-31 $-0.44B $0.52B -55.83%
2018-09-30 $-0.15B $0.79B -16.87%
2018-06-30 $-0.14B $0.80B -14.69%
2018-03-31 $0.06B $1.02B 6.15%
2017-12-31 $0.07B $1.02B 7.33%
2017-09-30 $0.08B $1.00B 7.84%
2017-06-30 $0.10B $0.99B 9.82%
2017-03-31 $0.10B $0.97B 10.53%
2016-12-31 $0.11B $0.96B 10.94%
2016-09-30 $0.11B $0.99B 11.35%
2016-06-30 $0.11B $1.00B 11.16%
2016-03-31 $0.11B $1.01B 10.91%
2015-12-31 $0.10B $0.99B 10.50%
2015-09-30 $0.09B $0.99B 8.67%
2015-06-30 $0.06B $0.98B 6.49%
2015-03-31 $0.06B $0.97B 6.00%
2014-12-31 $0.07B $0.99B 6.50%
2014-09-30 $0.08B $1.01B 7.81%
2014-06-30 $0.10B $1.03B 9.87%
2014-03-31 $0.11B $1.03B 10.85%
2013-12-31 $0.11B $1.03B 11.10%
2013-09-30 $0.11B $1.01B 10.94%
2013-06-30 $0.10B $0.99B 10.66%
2013-03-31 $0.11B $0.98B 10.88%
2012-12-31 $0.11B $0.97B 11.31%
2012-09-30 $0.11B $0.96B 11.37%
2012-06-30 $0.12B $0.95B 12.50%
2012-03-31 $0.12B $0.94B 12.58%
2011-12-31 $0.11B $0.92B 12.66%
2011-09-30 $0.11B $0.91B 12.65%
2011-06-30 $0.11B $0.90B 12.67%
2011-03-31 $0.11B $0.88B 12.97%
2010-12-31 $0.11B $0.86B 13.32%
2010-09-30 $0.12B $0.84B 15.05%
2010-06-30 $0.12B $0.82B 15.88%
2010-03-31 $0.12B $0.79B 15.75%
2009-12-31 $0.11B $0.77B 14.35%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.606B $10.701B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00